Skip to search formSkip to main contentSkip to account menu

Biniwas

Known as: Chiesi brand of binifibrate 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

binifibrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Effect of a modified fibrate (Biniwas Retard) on hemorheological alterations in hyperlipemic patients.
The effect of a binifibrate (Biniwas Retard, Wasserman) on the plasma lipids and hemorheological profile of 30 primary… 
1983
1983
Microhaemorheological properties of binifibrate. Part I: Experimental studies.
The microhaemorheological properties of 3-pyridine carboxylic acid 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]-1,3-propanediyl… 
1983
1983
Microhaemorheological properties of binifibrate. Part II: Preliminary open studies in patients with peripheral arteriopathies.
3-Pyridinecarboxylic acid 2-[2-(4-chlorophenoxy)-2-methyl-1-oxo-propoxy]-1,3-propanediyl ester (binifibrate, Biniwas) an anti… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)